About
Technology
Issues
FAQ
Links
Official Page
Neoadjuvant therapy with doxorubicin-cyclophosphamide followed by weekly paclitaxel in early breast cancer: a retrospective analysis of 200 consecutive patients treated in a single center with a median follow-up of 9.5 years
site/software ©
exaly
; All materials licenced under
CC by-SA
.